Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari
  • Home
  • Invasive Candidiasis (IC)

Invasive candidiasis (IC)

What is Invasive candidiasis (IC)?

IC refers to bloodstream or deep-seated infections caused by Candida spp.1 Candidemia specifically refers to bloodstream infections.1,2

Disease manifestation can vary depending on the species, due to different virulence factors, invasive potential and susceptibility to antifungal medication.1 In a hospital setting, Candida spp. colonisation has been observed on surfaces and medical devices.3 Nosocomial infections are an increasingly common route of infection and a concern for patients in high-risk groups.4

Pathogenesis

Pathogenesis occurs through colonisation of mucosal surfaces in the body, such as the intestines, or through the formation of biofilms on medical devices, such as catheters.1 Deficiencies in the host immune system can allow Candida spp. to breach the intestinal barrier through hyphal penetration and dissemination into the bloodstream.1 From here, the pathogen can move to different internal organs and establish disseminated infection, or can be localised to the bloodstream (candidemia).1

Epidemiology

The global incidence of IC is estimated at ~750,000 cases per year.4 In the USA, approximately 55% of all IFDs are caused by Candida spp.5

It is estimated that half of all candidemia infections occur in the intensive care unit (ICU), largely because patients in the ICU have one or several risk factors for disease.1 The cumulative incidence of IC in European ICUs is estimated to be 7.07 episodes per 1000 ICU admissions.6

The mortality rate for candidemia is estimated to be over 40%.4

Risk factors

Patients who are critically ill and immunocompromised, such as those with cancer or those undergoing bone marrow or solid organ transplant, are at increased risk of IC.7

Other factors associated with IC include:2,7,8

  • Renal impairment
  • Use of mechanical ventilation
  • Hospital stays longer than 10–15 days
  • Central venous catheterisation
  • Sepsis
  • Total parenteral nutrition
  • Use of broad-spectrum antibiotics
  • Increased age
  • Rare Candida spp. as causative pathogens
  • Abdominal surgery

Pathogenic species

  • C. albicans is the most common species that causes IC, accounting for nearly half of all Candida infections4,9
  • C. albicans, C. glabrata, C. tropicalis, C. parapsilosis and C. krusei together represent over 90% of all IC cases10
  • C. auris is an emerging pathogen that has been associated with outbreaks of IC in several countries, including Japan, India, the UK, Spain, the USA, Colombia and South Africa1,11 
  • This species is of particular concern as multi-drug resistance has been observed, alongside its ability to spread between individuals and rapidly colonise the skin12

References

  1. Pappas PG et al. Nat Rev Dis Primers. 2018;4:18026.
  2. Kullberg BJ and Arendrup MC. N Engl J Med. 2015;373:1445–1456.
  3. Cortés JA and Corrales IF. Invasive Candidiasis: Epidemiology and Risk Factors. In: Fungal Infection. London: IntechOpen, 2018.
  4. Bongomin F et al. J Fungi (Basel). 2017;3:57.
  5. Webb BJ et al. Open Forum Infect Dis. 2018;5:ofy187.
  6. Bassetti M et al. Crit Care. 2019;23:219.
  7. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: World Health Organization. Available at: https://www.who.int/publications/i/item/9789240060241. Accessed July 2023.
  8. Hoenigl M et al. Lancet Infect Dis. 2023;23:751–761.
  9. Pfaller MA et al. Open Forum Infect Dis. 2019;6:S79–S94.
  10. Antinori S et al. Eur J Intern Med. 2016;34:21–28.
  11. Chowdhary A et al. PLoS Pathog. 2017;13:e1006290.
  12. Sultan AS et al. Clin Infect Dis. 2021;72:178–179.

SciA-AFN-2400059 | November 2024